Comparative Tables of Bleeding Disorder Therapies by Brand

LA Kelley Communications provides downloadable tables that present clotting factor concentrates, novel therapies, gene therapies and adjunct therapies licensed for distribution in the US for hemophilia and von Willebrand disease. For factor concentrates, the data is presented by source material (plasma or recombinant), by class (hemophilia A, B, inhibitors, von Willebrand Disease), half-life and by manufacturer. 

Source: LA Kelley Communications, Inc., Communique, June 2026